Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.

From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

HIV is an infection that can be transmitted from one person to another through sexual activity, such as anal, oral, or vaginal sex. The terms “sexually transmitted infections (STIs)” and ...

Tremendous successes have been achieved in treating and caring for people living with HIV and in developing HIV prevention technologies such as pre-exposure prophylaxis (PrEP) and post-exposure ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

Early symptoms of mono and acute HIV infection include body aches, fatigue, fever, headaches, sore throat, and swollen lymph ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

No writing assistance was utilized in the production of this manuscript. Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting ...

The event will be held at the Branch Brook Park Cherry Blossom Welcome Center, between Heller Parkway and Mill Street.